LW

Lindsay Wakefield

Genetic Technologies Limited | Non-Executive Director
Dr Wakefield started Safetech Pty Ltd in 1985 and over the next 25 years, Safetech became a force in the Australian material handling and lifting equipment market, designing and manufacturing a wide range of industrial products. In 1993, he left medicine to become the full-time CEO of Safetech. In 2006, Safetech was awarded the Telstra Australian National Business of the Year. In 2013, Safetech merged and ultimately acquired Tiemen Materials Handling. He continues as the CEO of Safetech. It is Australia's manufacturer and supplier of dock equipment, freight hoists and custom lifting solutions. Safetech employs approximately 100 people. Wakefield has been a biotech investor for more than 20 years. Lindsay is also a member of Risk Committee.

Company and Role

Company
Title
Tenure
Since
GTG
GTG
Genetic Technologies Limited
  • Non-Executive Director
10yrs, 7mthSep 2014

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
GTG
GTG
Genetic Technologies Limited
30/06/24N/A94,182N/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
GTG
GTG
Genetic Technologies Limited
21/12/23
Expiry
5,000,000$0.150$750,000As advised by the company
GTG
GTG
Genetic Technologies Limited
21/12/20
Issued
5,000,000$0.007$35,000Issue of securities
GTG
GTG
Genetic Technologies Limited
02/06/20
Buy
1,663,341$0.005$9,148On-market trade
GTG
GTG
Genetic Technologies Limited
02/06/20
Sell
570,500$0.006$3,423On-market trade
GTG
GTG
Genetic Technologies Limited
23/05/17
Sell
7,000,000$0.009$63,000On-market trade. As per announcement on 25/05/2017.